International Journal of Clinical Oncology

, Volume 10, Issue 6, pp 425–428 | Cite as

Non-small cell lung cancer: radiation therapy for locoregional recurrence after complete resection

  • Takuhito Tada
  • Haruyuki Fukuda
  • Katsuhiro Nakagawa
  • Kaoru Matsui
  • Masako Hosono
  • Yoshie Takada
  • Yuichi Inoue



We investigated patterns of failure after radical radiation therapy in relation to the radiation field in patients with postsurgical locoregional recurrence of non-small cell lung cancer.


Between 1992 and 2002, 31 patients with locoregional recurrence were treated with radiation therapy. At the time of radiation therapy, the sites of recurrence were the bronchial stump, the regional lymph nodes, the chest wall, and both the regional lymph nodes and the chest wall in 7, 20, 3, and 1 patient, respectively. The prescribed dose was 60 Gy in 30 fractions over 6 weeks in all patients.


The response rate was 87%. The overall 1-year, 2-year, and 4-year Kaplan-Meier survival rates were 61%, 30%, and 15%, respectively, and the median survival time was 14 months. Locoregional relapse with or without distant metastasis occurred in 15 patients (in-field, 7; marginal, 7; out-field, 1), and distant metastasis alone occurred in 7 patients. The sites of marginal relapse were the upper margin in two patients, the ipsilateral margin in one patient, the contralateral margin in one patient, and the lower margin in three patients, respectively (in one patient, the data for marginal relapse overlapped). In all patients with relapse on the lower margin, the mediastinal lymph nodes were dissected at the initial surgery.


Postoperative recurrent non-small cell lung cancer showed distinctive features: the response rate was high, and the incidence of marginal relapse was also high, as in small cell lung cancer. The incidence of lower marginal relapse was high, in contrast to that in surgery-naive patients.

Key words

Non-small-cell lung cancer Radiation therapy Surgery Recurrence 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Onishi, H, Araki, T, Shirato, H,  et al. 2004Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multiinstitutional studyCancer10116231631PubMedCrossRefGoogle Scholar
  2. 2.
    Thomas, P, Rubinstein, L 1990Cancer recurrence after resection: T1 N0 non-small cell lung cancerAnn Thorac Surg49242247PubMedCrossRefGoogle Scholar
  3. 3.
    Field, R, Rubinstein, L, Weisenberger, T 1984Site of recurrence in resected stage I non-small cell lung cancer. A guide for future studiesInt J Radiat Oncol Biol Phys213521358Google Scholar
  4. 4.
    Immerman, S, Vanecko, R, Fry, W 1981Site of recurrence in patients with stage I and II carcinoma of the lung resected for cureAnn Thorac Surg322327PubMedCrossRefGoogle Scholar
  5. 5.
    Ishida, T, Yano, T, Maeda, K,  et al. 1990Strategy for lymphadenectomy in lung cancer three centimeters or less in diameterAnn Thorac Surg50708713PubMedGoogle Scholar
  6. 6.
    Jeremic, B, Shibamoto, Y, Milicic, B,  et al. 1999External beam radiation therapy alone for loco-regional recurrence of non-small-cell lung cancer after complete resectionLung Cancer23135142PubMedCrossRefGoogle Scholar
  7. 7.
    Emami, B, Graham, MV, Deedy, M,  et al. 1997Radiation therapy for intrathoracic recurrence of non-small cell lung cancerAm J Clin Oncol204650PubMedGoogle Scholar
  8. 8.
    Kagami, Y, Nishio, M, Narimatsu, N,  et al. 1998Radiotherapy for locoregional recurrent tumors after resection of non-small cell lung cancerLung Cancer203135PubMedCrossRefGoogle Scholar
  9. 9.
    Tada, T, Minakuchi, K, Matsui, K,  et al. 2004A single institutional subset analysis of the WJTOG study comparing concurrent and sequential chemoradiotherapy for stage III non-small-cell lung cancerRadiat Med22163167PubMedGoogle Scholar
  10. 10.
    Tada, T, Minakuchi, K, Koda, M,  et al. 1998Limited-stage small cell lung cancer: local failure after chemotherapy and radiation therapyRadiology208511515PubMedGoogle Scholar
  11. 11.
    Pritchard, RS, Anthony, SP 1996Chemotherapy plus radiotherapy compared with radiotherapy alone in the treatment of locally advanced, unresectable, non-small-cell lung cancer. A meta-analysisAnn Intern Med125723729PubMedGoogle Scholar
  12. 12.
    Cox, JD, Azarnia, N, Byhardt, RW,  et al. 1990A randomized phase I/II trial of hyperfractionated radiation therapy with total dose of 60.0 Gy to 79.2 Gy: possible survival benefit with greater than or equal to 69.6 Gy in favorable patients with Radiation Therapy Oncology Group stage III non-small-cell lung carcinoma: report of Radiation Therapy Oncology Group 83-11J Clin Oncol815431555PubMedGoogle Scholar
  13. 13.
    Vanuytsel, LJ, Vansteenkiste, JF, Stroobants, SG,  et al. 2000The impact of (18)F-fluoro-2-d-glucose positron emission tomography (FDG-PET) lymph node staging on the radiation treatment volumes in patients with non-small cell lung cancerRadiother Oncol27317324Google Scholar
  14. 14.
    Kamel, EM, Zwahlen, D, Wyss, MT,  et al. 2003Whole-body (18) F-FDG PET improves the management of patients with small cell lung cancerJ Nucl Med4419111917PubMedGoogle Scholar

Copyright information

© The Japan Society of Clinical Oncology 2005

Authors and Affiliations

  • Takuhito Tada
    • 1
  • Haruyuki Fukuda
    • 2
  • Katsuhiro Nakagawa
    • 3
  • Kaoru Matsui
    • 4
  • Masako Hosono
    • 1
  • Yoshie Takada
    • 1
  • Yuichi Inoue
    • 1
  1. 1.Department of RadiologyOsaka City University Graduate School of MedicineOsakaJapan
  2. 2.Department of RadiologyOsaka Prefectural Medical Center for Respiratory and Allergic DiseaseHabikinoJapan
  3. 3.Department of Thoracic SurgeryOsaka Prefectural Medical Center for Respiratory and Allergic DiseaseHabikinoJapan
  4. 4.Department of Thoracic MalignancyOsaka Prefectural Medical Center for Respiratory and Allergic DiseaseHabikinoJapan

Personalised recommendations